| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
6.782 |
Evidence |
|
| IARS |
IARS: Isoleucyl-tRNA synthetase, cytoplasmic |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
6.77 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
6.73 |
Evidence |
O
|
| PEX7 |
PEX7, PTS2R: Peroxisomal targeting signal 2 receptor |
PEX13 |
PEX13: Peroxisomal membrane protein PEX13 |
6.71 |
Evidence |
O
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
6.685 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
RELA |
RELA, NFKB3: Transcription factor p65 |
6.66 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
6.66 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
6.66 |
Evidence |
O
|
| EGR1 |
EGR1, ZNF225: Early growth response protein 1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
6.66 |
Evidence |
O
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
6.647 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
6.64 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
INSR |
INSR: Insulin receptor precursor |
6.632 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
6.632 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
6.63 |
Evidence |
|
| ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
6.62 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
RUNX1 |
IPI00218943 |
6.62 |
Evidence |
|
| DLL1 |
DLL1, UNQ146/PRO172: Delta-like protein 1 precursor |
MFNG |
MFNG: Beta-1,3-N-acetylglucosaminyltransferase manic fringe |
6.595 |
Evidence |
|
| MPHOSPH10 |
MPHOSPH10, MPP10: U3 small nucleolar ribonucleoprotein protein MPP10 |
C15orf12 |
IMP3, C15orf12, MRPS4: U3 small nucleolar ribonucleoprotein protein IMP3 |
6.565 |
Evidence |
O
|
| EXOC3 |
EXOC3, SEC6, SEC6L1: Exocyst complex component 3 |
EXOC2 |
IPI00215805 |
6.565 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
6.55 |
Evidence |
|
| ZNFN1A1 |
IKZF1, IK1, IKAROS, LYF1, ZNFN1A1: DNA-binding protein Ikaros |
ZNFN1A2 |
IKZF2, HELIOS, ZNFN1A2: Zinc finger protein Helios |
6.542 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
6.525 |
Evidence |
|
| IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
6.525 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
6.525 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PRLR |
PRLR: Prolactin receptor precursor |
6.525 |
Evidence |
|
-